FDA Approval of Implantable Microchips

In the early 2010s, the Food and Drug Administration approved the VeriChip, a subcutaneous microchip about the size of a grain of rice, for medical applications. Manufactured by Applied Digital Solutions of Delray Beach, Florida, the device could be implanted under the skin in a procedure taking less than 20 minutes with no stitches required. The chip stored a unique identifier code that, when scanned, released patient-specific medical information.

The technology was functionally similar to the UPC codes used in retail, but applied to human beings. At the time of FDA approval, the same basic technology had already been implanted in approximately one million pets for identification and tracking purposes.

Military and Emergency Management Applications

The potential applications of implantable chip technology extended well beyond individual medical records. In October 2011, PositiveID Corporation, the company behind VeriChip, announced an order for its microchips intended for use by the Israel Defense Forces. The stated purpose was disaster preparedness and emergency management.

PositiveID’s vice president of business development described the chips as having applications for healthcare organizations, military forces, and governments dealing with disaster preparedness and emergency response. The military procurement signaled that implantable identification technology was being evaluated not just as a consumer medical product but as infrastructure for managing populations during crisis situations.

The Incremental Adoption Model

Privacy advocates raised concerns about the trajectory of microchip adoption, noting that new surveillance technologies typically follow an incremental pattern. Technologies introduced as voluntary conveniences for specific populations often expand in scope over time as institutional infrastructure develops around them.

The pattern observed with other tracking technologies suggested a predictable sequence: initial adoption by early adopters and specialized populations such as military personnel and medical patients, followed by expansion into government benefit programs where participation could be tied to service access, and eventually broader implementation across public institutions.

Similar progression had been documented with other identification and surveillance technologies. Airport security screening, originally implemented for specific threat scenarios, expanded to encompass increasingly broad monitoring programs. Cell phone location tracking, initially a feature of the technology rather than its purpose, became a standard tool for law enforcement and commercial data collection.

Privacy Implications and Civil Liberties Concerns

The core privacy concern surrounding implantable chips was not the medical application itself but the dual-use potential of any technology capable of uniquely identifying and locating individuals. A chip that could store medical information could also serve as a tracking device, a financial identifier, or a requirement for accessing services.

Critics pointed to the fundamental asymmetry in such systems: the individuals being tracked had no control over how the data collected from their chips would be used, stored, or shared. Unlike an identification card that could be left at home, a subcutaneous implant was permanently with the individual, creating continuous identification capability.

The Broader Question of Technological Surveillance

The VeriChip and similar implantable technologies represented one node in a larger ecosystem of identification and tracking systems being developed and deployed in the early 21st century. From biometric databases to facial recognition to cell phone metadata collection, the technological capacity to monitor individual movements and behaviors was expanding rapidly.

The question raised by implantable chip technology was not whether such monitoring was technically possible, since it clearly was, but whether adequate legal and institutional safeguards existed to prevent mission creep from medical convenience to comprehensive surveillance. The history of other surveillance technologies suggested that once the infrastructure existed, its applications tended to expand well beyond original stated purposes.